The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma

Silvia Lampis(Bambino Gesù Children's Hospital), Roberto Tonelli(University of Modena and Reggio Emilia)
Journal of Experimental & Clinical Cancer Research
April 30, 2022
Cited by 23


Related Papers